Kelly Plueschke

Patient Registries: An Underused Resource for Medicines Evaluation

Patricia McGettigan, Carla Olmo, Kelly Plueschke et al. · Drug Safety · 2019 · 93 citations · Full text

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making

Elisabeth Bakker, Kelly Plueschke, Carla J. Jonker et al. · Clinical Pharmacology & Therapeutics · 2022 · 70 citations · Full text

Real-world Evidence, Pharmacotherapy, Research Ethics +22

Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation

Alexandra Păcurariu, Kelly Plueschke, Patricia McGettigan et al. · BMJ Open · 2018 · 60 citations · Full text

EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making

Kelly Plueschke, Patricia McGettigan, Alexandra Păcurariu et al. · BMJ Open · 2018 · 36 citations · Full text

What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?

Justina Januskiene, Andrej Segec, Jim Slattery et al. · Pharmacoepidemiology and Drug Safety · 2020 · 16 citations · Full text